The hospital sector is experiencing a surge in CEO departures—and research suggests that less than half of health systems are prepared for the financial and organizational impact that follows, Alex Kacik writes for Modern Healthcare.
CDC on Thursday released new Covid-19 guidelines, loosening quarantine and exposure recommendations. The agency also said that because of population-level immunity and available treatments, the risk of developing severe Covid-19 is low in the United States.
The public health emergency declaration for monkeypox gives the federal government the "power to ramp up its response, to change vaccination strategies, and loosen regulations that restrict availability of drugs and tests," which could lead the outbreak down three possible paths, Maryn McKenna writes for Wired.
A federal judge on Tuesday approved a $2.67 billion settlement in a years-long antitrust suit brought against Blue Cross Blue Shield companies on the behalf of employers and individual policyholders, Anna Wilde Matthews reports for the Wall Street Journal. Advisory Board's Max Hakanson shares the three biggest impacts of the settlement.
Most vaccinated individuals ages 50 and older say they will get an updated booster in the fall, prescriptions of Paxlovid reach more than 1 million in July, and more in this week's roundup of Covid-19 news.
President Joe Biden on Wednesday signed the Promise to Address Comprehensive Toxics Act into law "to help millions of veterans exposed to toxic substances during their military service," in today's bite-sized hospital and health industry news from the District of Columbia, Illinois, and New York.
